Skip to navigation Skip to content
Your Cart
  • My Account
Imagion Biosystems Logo
  • About Us
    • Leadership Team
    • Strategic Partnering
    • Careers
  • News
    • Company News
    • Resource Library
    • Scientific Posters
  • Our Technology
    • MagSense® Technology
      • MagSense® Product Pipeline
      • Applications
    • PrecisionMRX® Nanoparticles
      • SPION Applications & FAQ’s
  • Clinical Trial
  • Investor Hub
  • Contact Us
Search
  • Privacy Policy
  • Terms & Conditions
  • My account
  • Cart
  • Checkout
Twitter-square Facebook-square Linkedin Youtube

Quality Assurance Associate

February 23, 2023 May 13, 2023
This listing has expired.
Recent Posts
  • Pitt Street Research – “Detecting cancers earlier” with Imagion Biosystems
  • Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway 
  • Dr. Nina Webster Joins IBX Board of Directors
  • Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study
  • Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics
Categories
  • News (262)
  • Investor updates (383)
  • Scientific Publications (10)
  • Press & Media (20)
  • Events & Webinars (25)
  • Company Update (24)
  • Newsletters (9)

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Imagion Biosystems Logo

Contact us

  • info@imagionbio.com
  • Imagion Biosystems, Ltd. Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 3000, Australia
  • AU +61 3 9692 7222
  • Imagion Biosystems, Inc. PO Box 4410 Incline Village, NV 89450 United States

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube